The invention relates to compounds of Formula I ##STR00001## and their therapeutic uses, wherein substituent A is chosen from a substituted or unsubstituted aryl, heteroaryl, heterocyclic, or carboxylic group, B is chosen from a substituted or unsubstituted piperidine, homopiperidine, piperazine, pyrrolidine or azetidine group, R1 is chosen from hydro, alkyl, aryl, heteroaryl amino and halo, and L1 and L2 are as defined in the specification.

 
Web www.patentalert.com

< Methods of increasing cerebral blood flow

> Nucleobase phosphonate analogs for antiviral treatment

> Compositions comprising fusion polypeptides HIV-Nef and NGF, and methods of using the same

~ 00546